Cell models and drug discovery for mitochondrial diseases

Area of Science:

• Biochemistry and Molecular Biology
• Cell Biology
• Genetics

Background:

• Mitochondria are vital organelles involved in energy metabolism, apoptosis, reactive oxygen species (ROS) production, and calcium (Ca2+) homeostasis.
• Mitochondrial DNA (mtDNA) mutations are a key cause of mitochondrial disorders.
• Developing effective cell models for mitochondrial diseases remains a significant challenge, hindering drug discovery and mechanistic studies.

Purpose of the Study:

• To review and discuss various patient-specific cell models used in studying mitochondrial disorders.
• To highlight the characteristics, roles, and advancements of these models, particularly in drug screening.

Main Methods:

• Summarizing characteristics of patient-specific immortalized lymphoblastoid cells.
• Analyzing fibroblastoid cells for mitochondrial disorder research.
• Evaluating cytoplasmic hybrid (cybrid) cell lines.
• Assessing induced pluripotent stem cells (iPSCs)-derived differentiation cells.

Main Results:

• Patient-specific cell models offer valuable tools for understanding mitochondrial disorders.
• Different cell models possess unique advantages for specific research applications.
• These models show promise in advancing drug discovery and therapeutic strategies for mitochondrial diseases.

Conclusions:

• Patient-derived cell models, including iPSCs, are essential for advancing mitochondrial disease research.
• Further development and application of these cell models will accelerate targeted drug discovery and therapeutic interventions.
• Improved cell modeling is critical for overcoming current limitations in studying and treating mitochondrial disorders.